Page last updated: 2024-10-24

beta-glycerophosphoric acid and Uveitis

beta-glycerophosphoric acid has been researched along with Uveitis in 1 studies

beta-glycerophosphoric acid: plays role in mineralization of bone in vitro
glycerol 2-phosphate : A glycerol monophosphate having the phosphate group at the 2-position.

Uveitis: Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
" Although eye drops, a non-invasive topical treatment, could be a potential strategy to reduce side effects, it remains challenging to apply due to limited bioavailability mainly linked to poor retention time and permeation capacity for eye biological barriers."1.62Hydrogel eye drops as a non-invasive drug carrier for topical enhanced Adalimumab permeation and highly efficient uveitis treatment. ( Bai, J; Chen, Z; Deng, J; Feng, Y; He, H; Huang, J; Jiang, Z; McAlinden, C; Mei, C; Pan, L; Skiadaresi, E; Wang, Q; Xu, H; Xu, W; Yang, M; Ye, X; Yu, J; Zeng, Z; Zhang, J, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, Z1
Yang, M1
Wang, Q2
Bai, J1
McAlinden, C1
Skiadaresi, E1
Zhang, J1
Pan, L1
Mei, C1
Zeng, Z1
Yu, J1
Feng, Y1
Jiang, Z1
Xu, W1
Xu, H1
Ye, X1
He, H1
Deng, J1
Huang, J1

Other Studies

1 other study available for beta-glycerophosphoric acid and Uveitis

ArticleYear
Hydrogel eye drops as a non-invasive drug carrier for topical enhanced Adalimumab permeation and highly efficient uveitis treatment.
    Carbohydrate polymers, 2021, Feb-01, Volume: 253

    Topics: Adalimumab; Administration, Ophthalmic; Animals; Anti-Inflammatory Agents; Biocompatible Materials;

2021